Authoritative facts about the skin from DermNet New Zealand Trust. Progressive macular hypomelanosis (progressieve maculaire hypomelanose): vage bleke vlekjes op de romp, post-inflammatoire hypopigmentatie veroorzaakt door bacterien. Relyveld GN(1), Menke HE, Westerhof W. Author information: (1)The Netherlands Institute for Pigment Disorders, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Because of the highly characteristic clinical aspect and the light- and electron- microscopic histopathologic findings, we diagnosed progressive macular hypomelanosis (PMH). The aim of the present study was to clinically outline PMH and study its pathogenesis.
Based upon the literature suggesting improvement of PMH with antibiotic therapy to. It was originally described in patients with Fitzpatrick skin types V-VI from tropical countries. Hipomelanosis macular progresiva resuelta con peróxido de benzoilo y clindamicina tópicos. It occurs in all races and has been described in many parts of the world. The clinical picture was consistent with a diagnosis of progressive macular hypomelanosis (PMH) of the trunk. Treatment was initiated with topical benzoyl peroxide and clindamycin, and the lesions gradually resolved over several weeks.
It has also been called cutis trunci variata, nummular and confluent hypomelanosis, Creole dyschromia, and idiopathic multiple large-macule hypomelanosis.
Hypopigmented, confluent macules arise without prior onset of injury, inflammation, or known infection. UpToDate, electronic clinical resource tool for physicians and patients that provides information on Adult Primary Care and Internal Medicine, Allergy and Immunology, Cardiovascular Medicine, Emergency Medicine, Endocrinology and Diabetes, Family Medicine, Gastroenterology and Hepatology, Hematology, Infectious. Its cause is unknown and proposed treatments have had little effect. Unfortunately, PMH is still not included in the majority of current textbooks of dermatology. In this article we present an overview of the literature on PMH together with our own findings and opinions, and.
Dermatological practice in Martinique frequently encounters a bizarre skin condition presenting as a progressive and extensive hypomelanosis on the back. The course of this disorder is highly characteristic: it occurs mainly in females from 18–25 years of age, with a progressive development of round, pale. Although common, particularly in Fitzpatrick skin types IV-VI, this condition is frequently misdiagnosed and treated inadequately. There is no signs of inflammation on the borders of the lesions, no atrophy or scarring, no facial involvement. Family members did not show any similar skin manifestations. Although many treatment modalities have been proposed for this condition with variable success rates, there are few reports comparing their. Pityriasis alba, post-inflammatory hypopigmentation (atopic dermatitis, psoriasis), bacterial and fungal infections, neoplasms, vitiligo.
The results of the studies presented in this. In the lower back and abdomen, discrete lesions are distinguished while they are more confluent on the upper trunk. PMH – Progressive Macular Hypomelanosis. Progressive Macular Hypomelanosis listed as PMH. The study helps reducing the dearth of reports.
The skin microbiota, in particular the bacterium Propionibacterium acnes, is suggested to play a role. It is Progressive Macular Hypomelanosis. Although the underlying aetiology of this condition is unclear, there is circumstantial evidence that links the skin bacterium Propionibacterium acnes to the condition.
Keywords: progressive macular hypomelanosis ;. Citation: Selim MK, Ahmed EF, Abdelgawad MM, El-Kamel MF. All three studies also demonstrated that benzoyl peroxide and clindamycin were safe when used to treat PMH. Guillet G, Helenon R, Gauthier Y, Surleve-Bazeille JE, Plantin P, Sassolas B. Over the past 20 years, many other terms have been coined for this condition. How is Progressive Macular Hypomelanosis abbreviated? PMH stands for Progressive Macular Hypomelanosis.
PMH is defined as Progressive Macular Hypomelanosis very rarely.